Application 019938

Type
BLA
Sponsor
NOVO NORDISK INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001NOVOLIN RINSULIN RECOMBINANT HUMANINJECTABLE;INJECTION100 UNITS/MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0169-1833NovolinHuman InsulinNovo NordiskBLACurrent
0169-1833NovolinHuman InsulinNovo NordiskBLACurrent
0169-1833NovolinHuman InsulinNovo NordiskNDACurrent
0169-1833NovolinHuman InsulinNovo NordiskNDACurrent
0169-1833NovolinHuman InsulinNovo NordiskNDACurrent
0169-3003NovolinHuman InsulinNovo NordiskBLACurrent
0169-3003NovolinHuman InsulinNovo NordiskBLACurrent
0169-3003NovolinHuman InsulinNovo NordiskNDACurrent
0169-3003NovolinHuman InsulinNovo NordiskNDACurrent
50090-0497NovolinHuman InsulinA-S Medication SolutionsBLACurrent
50090-0497NovolinHuman InsulinA-S Medication SolutionsNDACurrent
64725-1833NovolinHuman InsulinTYA PharmaceuticalsNDACurrent
68071-1701NovolinHuman InsulinNuCare Pharmaceuticals,Inc.BLACurrent
68071-1701NovolinHuman InsulinNuCare Pharmaceuticals,Inc.NDACurrent
68071-1701NovolinHuman InsulinNuCare Pharmaceuticals,Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
72724SUPPL2022-11-27
72695SUPPL2022-11-25
66371APPL2020-03-23
60935SUPPL2020-03-23
60930SUPPL2020-03-23
54433SUPPL2020-03-23
54419SUPPL2020-03-23
41098SUPPL2020-03-23
34108SUPPL2020-03-23
34107SUPPL2020-03-23
34106SUPPL2020-03-23
34105SUPPL2020-03-23
34104SUPPL2020-03-23
20426SUPPL2020-03-23
19855SUPPL2020-03-23
19854SUPPL2020-03-23
19853SUPPL2020-03-23
19852SUPPL2020-03-23
19851SUPPL2020-03-23
19850SUPPL2020-03-23
11861SUPPL2020-03-23
11860SUPPL2020-03-23
11859SUPPL2020-03-23
11858SUPPL2020-03-23
11857SUPPL2020-03-23
11856SUPPL2020-03-23
1824SUPPL2020-03-23
1823SUPPL2020-03-23
1822SUPPL2020-03-23
1821SUPPL2020-03-23
1820SUPPL2020-03-23
1819SUPPL2020-03-23
1818SUPPL2020-03-23